Bristol Myers Squibb to present 60+ oncology studies at ASCO 2026
Go back to Bristol Myers Squibb to present 60+ oncology studies at ASCO 2026| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 55.66 +0.96 (1.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.70 | 52 Week High | $77.12 | |||
| Open | $55.39 | 52 Week Low | $49.03 | |||
| Day High | $55.69 | P/E | 36.14 | |||
| Day Low | $54.96 | EPS | $1.54 | |||
| Volume | 2,884,785 | |||||
